Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma. - Test2 - elhamkhani - TriplyDB

Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma.

Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma.

http://www.wikidata.org/entity/Q35080097

about

miR-155 as a Biomarker in B-Cell Malignancies MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients Correlation of pretreatment 18F-FDG uptake with clinicopathological factors and prognosis in patients with newly diagnosed diffuse large B-cell lymphoma.Dysregulated MicroRNA Expression Profiles and Potential Cellular, Circulating and Polymorphic Biomarkers in Non-Hodgkin Lymphoma Anti-Apoptotic Effects of Lentiviral Vector Transduction Promote Increased Rituximab Tolerance in Cancerous B-Cells Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis.Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736.Identification of potential biomarkers to differentially diagnose solid pseudopapillary tumors and pancreatic malignancies via a gene regulatory network.Coordinated loss of microRNA group causes defenseless signaling in malignant lymphoma.MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST.Circulating MicroRNA-21, MicroRNA-23a, and MicroRNA-125b as Biomarkers for Diagnosis and Prognosis of Burkitt Lymphoma in Children.Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting.MicroRNAs in Lymphoma: Regulatory Role and Biomarker Potential.miR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosis.Delivery of miR-155 to retinal pigment epithelial cells mediated by Burkitt's lymphoma exosomes.Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine.miRNAs in Normal and Malignant Hematopoiesis.miR-28 regulates the germinal center reaction and blocks tumor growth in preclinical models of non-Hodgkin lymphoma.Plasma microRNA profiling: Exploring better biomarkers for lymphoma surveillance.MiR-29 silencing modulates the expression of target genes related to proliferation, apoptosis and methylation in Burkitt lymphoma cells.MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma.Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets.Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.Aggressive B-cell lymphomas in the update of the 4th edition of the World Health Organization classification of haematopoietic and lymphatic tissues: refinements of the classification, new entities and genetic findings.Role of Bruton's tyrosine kinase in B cells and malignancies.Chromosomal abnormality variation detected by G-banding is associated with prognosis of diffuse large B-cell lymphoma treated by R-CHOP-based therapy.miR-5003-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization and direct targeting of E-cadherin.Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.Evaluation of latent membrane protein 1 and microRNA-155 for the prognostic prediction of diffuse large B cell lymphoma.MicroRNAs as Biomarkers of B-cell Lymphoma MiRNA Dysregulation in Childhood Hematological Cancer

P2860

Q26746573-BEFD625D-7B05-4886-A9A2-A0B03BAE6D79 Q26865275-BE881DEF-9A01-42C9-8F6F-B3B9A9C749C4 Q27314809-8174D2BB-4AA0-4A10-A142-2793AF3BBFFD Q28071905-7AB80D4A-9346-4EDA-BD03-A0668A112FC9 Q28551184-1BE8F358-9085-4ABE-B81A-8B141DFDE4B6 Q33573515-CEB414C9-4FEB-4726-A322-7017F9700F5D Q36068667-2BD114E4-B35C-4D27-BE7D-6C9E8CC9A2B3 Q36294213-69F0F9ED-C340-4F6D-8817-E2AE2CBFA6AF Q36350416-E1A5CF8F-5128-4397-9DBA-F7A85B0ACB16 Q36866382-A7C14781-9A85-4FFB-86C1-FDA98231B8AC Q37543840-BD255CD9-578F-4C3F-A870-64F0E84B6051 Q37725413-CBA9A416-4BBA-49CB-B27A-E075BF8CE4FA Q38599607-77AC0EB6-513D-46D0-B96B-108DC4F53B0D Q38780780-6F12BA30-96D2-42F3-96F5-0A087B12896A Q38849339-5A05A2A0-7DFD-43A5-9974-AA3A5D7394DC Q38882112-208BE487-8727-4929-87F5-995A5CEF2E41 Q39428267-5F7D38AE-9E3A-49FF-A8F6-DB97093A34AC Q40340268-9DDDF02B-5BDC-4C44-B0F5-997F18B174DB Q47110316-AC1A84D2-516C-4A3F-997B-9BC36FA4A1E4 Q47215137-C8E7EDCA-A98F-4730-8938-2E290C6D8DE3 Q47292045-B13D0CDF-3927-415B-9A38-3338BDDEEF53 Q47571040-DEC54053-4CA5-4F60-8CEA-A07ECD1994CF Q48108703-855C5F2D-5792-40BF-BBE1-03B626D25FC4 Q48338600-4B6B7205-64E4-4758-A10C-6F33697D1526 Q49888075-8507DE04-3643-45CA-AC8D-EE2DF5D84794 Q50145904-66D4CE5E-9E87-46E3-BF89-C64670CD9D12 Q51711265-13E6F04D-0FC8-433D-80B3-D426F6486FAA Q54918383-BCE6F2C2-A874-4952-BE80-BFD17753D408 Q54962558-7925D4DB-3232-408F-A68B-66C66389E372 Q57814100-372C18AE-2C68-4CC4-BA3F-E3404385B02F Q58753107-2B1BB636-F24A-4BD9-A504-63CBD7AAA54F

P2860

Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma.

http://www.wikidata.org/entity/Q35080097

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Global microRNA expression pro ...... in aggressive B-cell lymphoma.

@ast

Global microRNA expression pro ...... in aggressive B-cell lymphoma.

@en

type

label

Global microRNA expression pro ...... in aggressive B-cell lymphoma.

@ast

Global microRNA expression pro ...... in aggressive B-cell lymphoma.

@en

prefLabel

Global microRNA expression pro ...... in aggressive B-cell lymphoma.

@ast

Global microRNA expression pro ...... in aggressive B-cell lymphoma.

@en

P1433

Q35080097-0FC63412-9B1E-444C-91FA-D18EB4A4C54D

P1476

Q35080097-4A0816F5-433C-4915-A131-2F8E68C45CA3

P2093

Q35080097-3590DC19-3015-46AF-AE9D-088E5C4537AA

Q35080097-371F987C-EE06-4E7F-9208-258B61C542E4

Q35080097-4813052C-730F-4A46-A63C-6425573F8EF7

Q35080097-49557DA2-33B0-466E-83B6-952BE7CB5670

Q35080097-4C686B87-6105-4DD9-9AEC-AD0DC0B166DC

Q35080097-563A31EA-D870-4C94-8064-5F8D0ECB82C7

Q35080097-62730255-1FFA-4D56-B5E1-C63500C4CD94

Q35080097-67D2155D-47D7-4614-B982-2FDE054F3787

Q35080097-70895FE3-61B1-4610-A68F-44C09C5CA332

Q35080097-711AFD16-23B3-4112-86F9-1B2C986730A3

P2860

Q35080097-0174BCD6-9436-43C8-8738-F496D8B5BEC7

Q35080097-0634F8FE-2D17-4B6D-969A-E731B3BA642B

Q35080097-08B8AEA4-FE08-4DD1-A103-CD237833028E

Q35080097-09C8EE3C-10A3-4DF9-8301-F6989390F0AE

Q35080097-11F4971C-AD5C-4D66-B0B1-400350F34709

Q35080097-14CEA7B6-1B92-4142-B5BF-D6ED3038DEB5

Q35080097-17C3D3DB-AD41-4209-8B52-42C6E6E8FF12

Q35080097-17C447DC-E2A6-40D0-B043-615D8E82E862

Q35080097-1DAA488E-7AF1-4F38-8A01-C09D6A4F5705

Q35080097-24A15FBA-C6CD-40FD-ACA4-BF2C102B2467

P304

Q35080097-06742BEE-B1DF-4792-9EA2-3D224198B8A6

P31

Q35080097-513AB71D-42D7-4766-9AE8-B4A282267ACF

P356

Q35080097-BCB4E991-FBCD-4174-891A-F9F138B0F02B

P407

Q35080097-1CD91328-5EF3-490E-838C-70F5C7891BBA

P433

Q35080097-BAE14F0B-97BB-436D-8CE4-33D4A18AE085

P478

Q35080097-57B69CB2-A0D8-4297-BB90-BEB2C85CE3F7

P50

Q35080097-00D65097-209F-4604-99ED-881A88D5F797

Q35080097-51EC1F14-472F-4295-B9D8-B1FEA4595DE9

Q35080097-550BB76B-4C90-45CC-BA3A-251074F93A17

Q35080097-5A7D337F-063E-4286-9381-5F3209667746

Q35080097-6235F1D0-3DA2-4259-85B3-7D7DA4392228

Q35080097-68388848-18DE-4A03-9933-332E59D81468

Q35080097-69253601-F314-4EC8-9BAA-C9A7DDDF18C9

Q35080097-95D4E5D1-C33F-41C8-98F0-207127041A14

Q35080097-B683F442-F036-4C7A-B07E-B508182A542A

Q35080097-C240EC1D-0940-4EFF-B6AB-7516187DC554

P577

Q35080097-9258EEED-3B7C-4588-AC9D-DBD46DFAA4FE

P698

Q35080097-FC345FDD-A9F2-4405-A403-6D5811CC26C8

P921

Q35080097-508EC977-8B97-43CB-838A-7B10208911C8

P932

Q35080097-74A9F5C4-BA88-45B1-845D-12B33024E8E5

P356

BLOOD-2014-04-566778

P1433

P1476

Global microRNA expression pro ...... in aggressive B-cell lymphoma.

@en

P2093

Andreas Rosenwald

http://www.w3.org/2001/XMLSchema#string

Chao Wang

http://www.w3.org/2001/XMLSchema#string

Cuiling Liu

http://www.w3.org/2001/XMLSchema#string

Cynthia M Lachel

http://www.w3.org/2001/XMLSchema#string

Elaine Jaffe

http://www.w3.org/2001/XMLSchema#string

George Wright

http://www.w3.org/2001/XMLSchema#string

German Ott

http://www.w3.org/2001/XMLSchema#string

James R Cook

http://www.w3.org/2001/XMLSchema#string

Javeed Iqbal

http://www.w3.org/2001/XMLSchema#string

Joseph Rohr

http://www.w3.org/2001/XMLSchema#string

P2860

Accumulation of miR-155 and BIC RNA in human B cell lymphomas

Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma

MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer

Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP

Widespread microRNA repression by Myc contributes to tumorigenesis

miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells

MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

Semi-supervised methods to predict patient survival from gene expression data

P304

1137-1145

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2014-04-566778

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P50

Timothy W McKeithan

Sharathkumar Bhagavathi

Randy D Gascoyne

Dennis D Weisenburger

James O Armitage

P577

2014-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25498913

http://www.w3.org/2001/XMLSchema#string

P921

microRNA expression

P932

4326773

http://www.w3.org/2001/XMLSchema#string